Navigation Links
China Focus@San Francisco to Offer 1-on-1 Partnering Opportunities
Date:1/10/2020

Representatives with MyBioGate announced that they are organizing the largest China-themed partnering conference during JPM Week. The China Focus@San Francisco partners conference will be held on 12 January 2020 at the Grand Hyatt San Francisco from 8 am to 7 pm.

“China Focus would like to be your gateway to China’s healthcare and life science industry. For the overseas biopharmas interested in this huge market with enormous potential, partnering is the preferred approach,” said Miao Guo, Vice President of Operations and spokesperson for MyBioGate and added, “as the largest China-themed partnering conference during JPM Week, China Focus@San Francisco is a golden opportunity for 1-on-1 meetings to connect with Chinese decision-makers.”

“More than 300 business leaders and enthusiastic investors are ready to schedule personal meetings with you,” pointed out Guo.

Guo highlighted that China Focus @San Francisco is a partnering forum designed to provide a meaningful platform to inform, inspire, and foster cross-border partnerships in life science and healthcare.

“China embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval, stressed Guo. “For life science and healthcare companies outside of China, you need to find the right partners and the right resources to bring your products to China to adapt to the difference in culture, regulation, reimbursement, etc. Chinese biotechs are also actively seeking global market entry opportunities and oversea partners.”

China's domestic pharmaceutical consumption has increased dramatically in the past several years. By 2020, China’s pharmaceutical market volume is expected to grow to USD 220 billion, becoming the second-largest market after the United States, as reported by Deloitte.

As for who should attend the event, Guo emphasized that the event is ideal for investors, life science innovators and entrepreneurs, biotech & big pharma companies, Medtech (device and diagnostics) manufacturers and distributors, service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.), and healthcare providers.

Main topics to be covered during China Focus@San Francisco are cross-border investments, Innovations going to China: regulation, market access, manufacturing and distribution
Chinese innovations going west: partnership for capital and market access in the U.S.

For more information, please visit https://events.mybiogate.com/sanfrancisco/

About China Focus

CHINA FOCUS is a one-of-a-kind partnering forum with a mission of connecting essential players and resources in the life science and healthcare ecosystem between China and the rest of the world. It brings together investors, pharma leaders, and innovators around the globe for an exclusive partnering event designed to inspire, inform, and foster cross-border investment and collaboration.

Since 2018, CHINA FOCUS has been successfully held in San Francisco, Philadelphia, Boston, and Vienna, attracting more than 600 companies and 800 executives worldwide. It has become a name brand and the go-to event for cross-border partnerships between China and the rest of the world.

Contact Details:

Feier Chen

Manager of Marketing

7707 Fannin Street
Ste. 200
Houston, TX 77054

United States

Phone: (832) 497-2220

Email: feier.chen (at) mybiogate (dot) com

Source: MyBioGate Inc. (event.mybiogate.com)

Read the full story at https://www.prweb.com/releases/china_focus_san_francisco_to_offer_1_on_1_partnering_opportunities/prweb16827237.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
2. Hemp, Inc. Signs Letter of Intent with One of Chinas Largest Agricultural Producers, Yasheng Group
3. China Pharmaceutical Market Guidebook Series (4) 2013 Report
4. Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
5. China Biologic Comments on the Proposed Shanghai RAAS Transaction
6. China Nepstar Chain Drugstore Ltd. Announces Appointment of New Director
7. China Nepstar Chain Drugstore Ltd. Reports First Quarter 2013 Financial Results
8. iBio Obtains New IP Protection in China
9. China & North East Asia Medical Device Market Reports
10. China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling Chan
11. OrthoTec China 2013 is Coming Up Soon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... ... The Team Type 1 Foundation, a nonprofit organization pursuing a global mission ... a partnership with VeloCity, a fundraising ride benefiting Grady Hospital, around the shared goals ... May 2nd and begins on the Mercedes-Benz Stadium field and ends at the Home ...
(Date:2/19/2020)... ... ... The swine flu (H1N1) was the virus that spread from animals to ... Although the U.S. has eradicated this disease after its first and only occurrence ... posing a risk from trading partners. , In a new article released in ...
(Date:2/15/2020)... Fla. (PRWEB) , ... February 14, 2020 , ... ... has established an "oral-systemic” link between the organisms that cause inflammatory gum disease ... from Tampa-based ProBiora Health?? , offers new tools in the fight against ...
Breaking Medicine Technology:
(Date:2/21/2020)... Ariz. (PRWEB) , ... February 21, 2020 , ... ... company providing nutrition and lifestyle solutions, has announced its third and final round ... . This Judging Period’s finalists are John Birr of Markdale, Ontario; Taiya Farrell ...
(Date:2/19/2020)... ... 19, 2020 , ... Spaulding Youth Center is thrilled to ... Flutie, Jr. Foundation for Autism. The grant will directly support Spaulding’s initiative to ... program will include the hiring of a fitness professional who will complete the ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... the scope of regulations and requirements that currently govern medical device manufacturers under ... which extends until 25 May 2020. Major changes from the previous MDD include:, ...
(Date:2/16/2020)... ... February 16, 2020 , ... Accumen Inc., ... partnering with AABB and The Joint Commission to provide a complimentary series of ... (directors, managers, coordinators and transfusion safety officers) within U.S. hospitals. , ...
(Date:2/14/2020)... ... February 14, 2020 , ... ScripHessco ... Care During Pregnancy. The guide breaks down the benefits of chiropractic care during ... chiropractic care during pregnancy is quite beneficial to the mother’s health. Seeing a ...
Breaking Medicine News(10 mins):